Translation of Antibiofilm Technologies to Wounds and Other Clinical Care
Nearly 80% of global bacterial infections are associated with biofilm bacteria (Joo, Otto, Chem Biol 19:1503–1513, 2012). In contrast to planktonic bacteria, biofilms are a complex, organized bacterial community possessing a sophisticated protective armor, in the form of the extracellular polymeric substance (EPS), which acts as a robust defense mechanism against eradication. Chronic biofilm infections affect 17 million people annually, and approximately 550,000 people die as a result of their chronic infections (Wolcott et al J Wound Care 19:45–50, 2010). The challenge with biofilm-related infections is that they cannot be adequately confirmed via diagnostic tests in the clinical setting, and, more importantly, they are intrinsically resistant to host immunity, antibiotics, and biocides. This renders current therapeutic options inadequate to successfully eradicate the infection. Next Science™ has applied novel material science methods to combat biofilm through its innovative Xbio™ technology. Xbio technology, which includes the proprietary product, BlastX™, works by disrupting the biofilm matrix and creating an environment that compromises the biofilm’s structural integrity. In doing so, the EPS can be broken down and removed, thereby allowing the pathogens within the environment to be targeted and preventing the biofilm’s reformation.
KeywordsWound Biofilm Infection BlastX Topical Healing
Dr. Myntti has financial interest in Next Science and the technologies discussed.
- 7.Flemming, H. C., & Wingender, J. (2010). The Biofilm Matrix. Nature Reviews Microbiology, 8, 623–633.Google Scholar
- 8.Performance of the Massachusetts Health Care System Series: A focus on provider quality. CHIA Center for Health Information and Analysis, chiamass.gov.
- 15.Carroll, K., Hobden, J., Miller, S., Morse, S., Mietzner, T., Detrick, B., Mitchell, T., McKerrow, J., & Sakanari, J. (2016). Jawetz, Melnick, & Adelbergs medical microbiology (27th ed.). Shenzen: McGraw-Hill.Google Scholar
- 16.Kim et al. (2018). Wounds, 30(5), 114–119. Epub 2018 February 23 (Biofilms Made Easy (wounds international) – Phillips; Skin and Wound Care 2013 – Kevin Wu; Wound Education Update Feb 2014 – Wounds UK Best Practice Statement)Google Scholar
- 19.Ryder, M. (2005). Catheter related infections – It’s all about biofilms. Topics in Advanced Practice Nursing eJournal, 5(3), 1–6.Google Scholar
- 20.Data on file. Center for Biofilm Engineering at Montana State University. Next Science Report TR-10-12-004.Google Scholar
- 21.Mallefet, P., & Dweck, A. C. (2008). Mechanisms involved in wound healing. Biomedical Scientist, 52(7), 609.Google Scholar
- 22.Next Science website. http://www.nextscience.com
- 23.Code of Federal Regulations. https://www.fda.gov/medicaldevices/deviceregulationandguidance/overview/default.htm
- 25.Evaluation of Automatic Class III Designation (De Novo). FDA.gov https://www.fda.gov/medicaldevices/deviceregulationandguidance/howtomarketyourdevice/premarketsubmissions/ucm462775.htm